 Norwood, MA, Jan. 20, 2021 GLOBE NEWSWIRE -- Corbus Pharmaceuticals Holdings, Inc. NASDAQ: CRBP Corbus or the Company, a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced it will participate in the New York Academy of Sciences webinar on January 27, 2021 on the endocannabinoid system as a target for therapeutic agents. 